PDS Biotechnology Corpora... (PDSB)
undefined
undefined%
At close: undefined
1.75
-4.63%
After-hours Dec 13, 2024, 05:19 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Net Income -42.94M -40.85M -16.92M -14.85M -7.00M -40.87M -50.86M -38.82M -28.08M -12.20M -6.88M
Depreciation & Amortization 17.36K 86.00 5.36K 15.61K 98.41K 174.35K 182.92K 100.12K 53.12K 31.23K 4.44K
Stock-Based Compensation 7.61M 5.20M 4.11M 452.29K 3.18M 7.61M 6.40M 5.31M 2.90M 1.30M 260.36K
Other Working Capital -5.96M 4.57M 181.64K 852.16K -2.63M 541.19K 2.18M -638.12K 1.33M 1.17M -619.53K
Other Non-Cash Items 3.84M 5.47M 241.03K 160.68K -9.36M 531.67K 363.91K 175.91K 1.92M -575.98K 854.34K
Deferred Income Tax -1.97M - - - -381.51K 2.82M 141.28K 268.80K 198.96K 35.29K -
Change in Working Capital -199.28K 4.47M 75.82K 1.07M -4.60M -3.43M 3.07M 782.43K 1.26M 1.70M -2.28M
Operating Cash Flow -33.64M -25.71M -12.49M -13.15M -18.07M -33.15M -40.70M -32.19M -21.75M -9.72M -8.04M
Capital Expenditures -4 - - - - - -188.72K -686.71K -1.31M -884.79K -136.89K
Acquisitions - - - - 29.11M - - - - - -
Purchase of Investments - - - - - - - - - - -
Sales Maturities Of Investments - - - - - - - - - - -
Other Investing Acitivies - - - - 275.00K - - -687.00K - - -
Investing Cash Flow - - - - 29.38M - -188.72K -686.71K -1.31M -884.79K -136.89K
Debt Repayment -59.30K 25.00M - - - -15.56K 5.00M 9.53M 2.47M 1.55M 100.00K
Common Stock Repurchased - - - - - - - - - - -22.05K
Dividend Paid - - - - - - - - - - -
Other Financial Acitivies 308.94K -568.87K 344.13K 70.46K - 1.51M 171.34K -219.04K 50.99M 14.92M 15.82M
Financial Cash Flow 16.38M 34.29M 48.89M 29.83M 750.00K -20.27M 22.55M 9.08M 139.52M 16.47M 15.90M
Net Cash Flow -17.26M 8.58M 36.40M 16.68M 12.06M -53.42M -18.33M -23.79M 116.46M 5.87M 7.72M
Free Cash Flow -33.64M -25.71M -12.49M -13.15M -18.07M -33.15M -40.89M -32.88M -23.06M -10.60M -8.18M